A Pilot Study to Determine the Effect of a Cobiotic Formulation on the Fecal Bacteroidetes: Firmicutes Ratio in Pre-Diabetic Subjects
Phase of Trial: Phase II
Latest Information Update: 11 Aug 2014
At a glance
- Drugs NM 504 (Primary)
- Indications Prediabetic-state
- Focus Pharmacodynamics
- Acronyms PrCo
- Sponsors MicroBiome Therapeutics
- 23 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Feb 2014 Positive top-line results published in a MicroBiome Therapeutics media release.
- 16 Dec 2013 MicroBiome Therapeutics completed bridge financing intended to support completion of this trial, according to a company media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History